18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: Delineation by radiation oncologists vs. joint outlining with a PET radiologist?

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1040-1051

  Hanna, Gerard G ^a,b   Carson, Kathryn J ^c   Lynch, Tom ^b   McAleese, Jonathan ^b   Cosgrove, Vivian P ^b   Eakin, Ruth L ^b   Stewart, David P ^b   Zatari, Ashraf ^b   O'Sullivan, Joe M ^a,b   Hounsell, Alan R ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Computed tomography; Non small cell lung cancer; Positron emission tomography; Radiotherapy planning; Target volume definition

Indexed keywords

COMPUTED TOMOGRAPHY; CONCORDANCE INDEX; F-FLUORODEOXYGLUCOSE; GROSS TUMOR VOLUME; INDUCTION CHEMOTHERAPY; MEAN PERCENTAGE; NON-SMALL-CELL LUNG CANCER; OPTIMAL PROTOCOLS; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; RADIATION ONCOLOGISTS; RADIOTHERAPY PLANNING; RADIOTHERAPY TREATMENT PLANNING; RANK TEST; TARGET VOLUME DEFINITION; TARGET VOLUMES; VOLUME CHANGE;

BIOLOGICAL ORGANS; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; ELECTRONS; POSITRONS; RADIATION; RADIOTHERAPY;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING; TUMOR VOLUME; WILCOXON SIGNED RANKS TEST; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; ONCOLOGY; PATHOLOGY; RADIOGRAPHY; REMISSION; SCINTISCANNING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIATION ONCOLOGY; RADIOPHARMACEUTICALS; REMISSION INDUCTION; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77956602312     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.060     Document Type: Article

References (16)

1. X. Qiao, O. Tullgren, and I. Lax The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
2. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Franais de Pneumo-Cancérologie NPC 95-01 Study J Clin Oncol 23 2005 5910 5917
3. E. Toloza, L. Harpole, and F. Detterbeck Noninvasive staging of non-small cell lung cancer: A review of the current evidence Chest 123 2003 137S 146S (Pubitemid 36135711)
4. L.S. Freudenberg, S.J. Rosenbaum, and T. Beyer PET versus PET/CT dual-modality imaging in evaluation of lung cancer Radiol Clin North Am 45 2007 639 644
5. 18FDG-positron emission tomography in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 2007 709 719
6. M.P. MacManus, K. Wong, and R.J. Hicks Early mortality after radical radiotherapy for non-small cell lung cancer: Comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral centre Int J Radiat Oncol Biol Phys 52 2002 351 361
7. S. Senan, J.S. van Sornsen de Koste, and M. Samson Evaluation of a target contouring protocol for 3D conformal radiotherapy in nonsmall cell lung cancer Radiother Oncol 53 1999 247 255
8. P. Giraud, S. Elles, and S. Helfre Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists Radiother Oncol 62 2002 27 36
9. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer J Nucl Med 46 2005 1342 1348
10. A. van Baardwijk, G. Bosmans, and L. Boersma PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumour and involved nodal volumes Int J Radiat Oncol Biol Phys 68 2007 771 778
11. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
12. Hanna GG, McAleese J, Carson KJ, et al. 18F-FDG PET-CT simulation for non-small cell lung cancer: What is the impact in patients already staged by PET-CT? Int J Radiat Oncol Biol Phys. In press.
13. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
14. P. Jarritt, A. Hounsell, and K.J. Carson Use of combined PET/CT images for radiotherapy planning: Initial experiences in lung cancer Br J Radiol Suppl 28 2005 33 40
15. J.M. Bland, and D.G. Altman Agreement between methods of measurement with multiple observations per individual J Biopharm Stat 17 2007 571 582
16. C.B. Caldwell, K. Mah, and M. Skinner Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int J Radiat Oncol Biol Phys 55 2003 1381 1393